October 24, 2014 11:48 PM ET

Pharmaceuticals

Company Overview of Acretia, Inc.

Executive Profile

Neal Rosen Ph.D., M.D.

Member of the Scientific Advisory Board, TetraLogic Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 9 different industries.

See Board Relationships
----

Background

Dr. Neal Rosen, Ph.D., M.D. served as a Scientific Consultant of NexGenix Pharmaceuticals Holdings, Inc. Dr. Rosen is a Member in the Department of Medicine and in the Molecular Pharmacology and Chemistry Program at Memorial Sloan-Kettering Cancer Center, where he serves as the Head of Developmental Therapeutics and Director of the Center for Mechanism-Based Therapeutics. Dr. Rosen is an expert in the interface between basic biology and clinical oncology. He is world-renowned ...

Corporate Headquarters

51 Follen Road
Lexington, Massachusetts 02421

United States

Phone: 781-652-0200
Fax: 270-913-2761

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Albert Einstein College of Medicine
MD
Albert Einstein College of Medicine
BA
Columbia College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acretia, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.